Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-09-23

Clinical Trial Update: Observational Study of Deferiprone (Ferriprox®) in the Treatment of Superficial Siderosis

View source ↗

Summary

An observational clinical trial update evaluating deferiprone (Ferriprox) for superficial siderosis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FERRIPROX (deferiprone)

Snippet

Sponsor: Johns Hopkins University | Conditions: Superficial Siderosis | Status: COMPLETED | Results posted: 2019-09-23